Latest California Healthline Stories
KHN, in collaboration with PBS NewsHour, reports on the skyrocketing cost of insulin — and the trend’s deadly consequences. The price in the U.S. nearly doubled from 2012 to 2016, prompting some patients and activists to travel to Canada, where insulin can be 90% cheaper.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
En sus rondas regulares en el Hospital Keck de la Universidad del Sur de California (USC), el doctor David Armstrong vive de cerca la injusticia brutal de la atención médica estadounidense. Cada semana, docenas de pacientes con diabetes llegan a verlo con heridas profundas, infecciones graves y mala circulación, complicaciones debilitantes de una enfermedad que […]
In California, people who are black or Latino are more than twice as likely as whites to undergo amputations related to diabetes, a Kaiser Health News analysis found. The pattern is not unique to California.
An estimated 1.25 million Americans have Type 1 diabetes and cannot live without insulin. Sen. Kamala Harris’ claim that 1 in 4 diabetes patients cannot afford their insulin is a shockingly high number, so we decided to dig into the sparse data.
The Adelanto ICE Processing Center houses nearly 2,000 people in California. Federal, state and watchdog reviews say the Florida-based firm that runs the facility fails to provide adequate health care.
During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.
Only by the bizarre logic of the U.S. pharmaceutical industry does this drug count as any kind of generic.
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.